GleamWall
中文EN

KPRX KIORA PHARMACEUTICALS INC

Pharmaceutical Preparations · Nasdaq · SEC CIK 1372514 · Fiscal year ends 12/31

Financial factors as of 2025-03-31 (2025Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY-99.9%
TTM net income YoY-529.2%
TTM EPS YoY84.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-55,210.8%
Net margin-60,257.3%
FCF margin—
EBITDA margin-55,137.5%

Returns

ROE-41.1%
ROA-31.5%
ROIC (approx.)-74.1%
Asset turnover0.00x

Leverage & solvency

Liabilities / assets30.3%
Debt / equity0.00x
Current ratio5.14x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.64x
Accruals ratio-11.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$0$16.02M
R&D expense$10.78M$7.84M
SG&A expense$5.75M$5.54M
Operating income-$12.83M$4.51M
Interest expense$19,960$21,446
Pretax income-$12.12M$5.66M
Income tax-$1.28M$2.07M
Net income-$10.84M$3.59M
EBITDA-$12.81M$4.53M
EPS (basic)-2.600.93
EPS (diluted)-2.640.87
Weighted avg. shares (diluted)4.10M4.13M
Balance sheet
Cash & equivalents$8.70M$3.80M
Short-term investments$8.39M$23.00M
Receivables$1.52M$601,197
Current assets$21.75M$29.71M
PP&E, net$91,672$5,232
Intangibles$2.06M$6.69M
Total assets$24.25M$36.48M
Current liabilities$3.63M$6.01M
Total liabilities$8.13M$10.72M
Shareholders' equity$16.13M$25.76M
Shares outstanding3.76M3.00M
Cash flow statement
Operating cash flow-$9.96M$8.56M
Capital expenditure$110,789$6,256
Free cash flow-$10.07M$8.55M
Investing cash flow$14.43M-$22.66M
Financing cash flow$265,655$15.50M
Depreciation & amortization$24,801$19,205
Stock-based compensation$900,236$656,593

Free plan shows the latest 2 periods; Pro shows all 12 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.